ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,255Medicare Part D Prescriptions Filled, Including Refills

Rank: 67 out of 1269

$676K Total Retail Price of All Prescriptions

Rank: 61 out of 1269

250 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 250 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 250 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 8,792 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 431 413 1 4
SIMVASTATIN 331 260 2 3
LISINOPRIL 287 241 3 1
OMEPRAZOLE 256 245 4 8
FUROSEMIDE 253 240 5 5
GABAPENTIN 233 180 6 17
AMLODIPINE BESYLATE 209 189 7 2
METOPROLOL TARTRATE 208 196 8 6
WARFARIN SODIUM 190 190 9 12
SPIRONOLACTONE 185 169 10 77
POLYETHYLENE GLYCOL 3350 174 169 11 50
ATORVASTATIN CALCIUM 167 156 12 7
FLUTICASONE PROPIONATE 146 132 13 40
QUETIAPINE FUMARATE 145 92 14 53
LIDODERM 142 139 15 56
MIRTAZAPINE 137 126 16 24
SERTRALINE HCL 133 127 17 23
DONEPEZIL HCL 125 125 18 22
NAMENDA 124 124 19 38
LOSARTAN POTASSIUM 112 110 20 15
CEFUROXIME 109 106 21 171
ZOLPIDEM TARTRATE 108 101 22 19
TRAMADOL HCL 107 104 23 16
OXYBUTYNIN CHLORIDE ER 103 69 24 130
METFORMIN HCL 99 87 25 9
TAMSULOSIN HCL 94 93 26 31
ADVAIR DISKUS 92 89 27 46
POTASSIUM CHLORIDE 83 71 28 26
AZITHROMYCIN 80 77 29 42
DIVALPROEX SODIUM 78 31 30 54
CITALOPRAM HBR 76 75 31 21
SPIRIVA 76 76 31 64
ATENOLOL 76 60 31 14
BENZTROPINE MESYLATE 76 24 R 31 108
ESCITALOPRAM OXALATE 74 71 35 58
HYDROCODONE-ACETAMINOPHEN 74 56 S3 35 20
ALLOPURINOL 72 72 37 49
METOPROLOL SUCCINATE 71 68 38 13
CIPROFLOXACIN HCL 69 66 39 66
SPIRONOLACTONE-HCTZ 61 56 40 228
LYRICA 58 44 41 92
RISPERIDONE 56 56 42 43
GLIMEPIRIDE 56 56 42 57
PRAVASTATIN SODIUM 54 51 44 11
OXYCONTIN 54 54 S2 44 116
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 31 46 33
CARBIDOPA-LEVODOPA 53 53 46 78
DIVALPROEX SODIUM ER 53 0 46 176
FENTANYL 53 53 S2 46 105
FINASTERIDE 52 52 50 112
FLUOCINONIDE 51 40 51 255
CARVEDILOL 51 45 51 29
CLOZAPINE 51 0 51 185
NITROFURANTOIN 51 51 51 210
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.